欢迎访问《岭南现代临床外科》官方网站,今天是

岭南现代临床外科 ›› 2017, Vol. 17 ›› Issue (03): 275-277.DOI: 10.3969/j.issn.1009-976X.2017.03.005

• 论著与临床研究 • 上一篇    下一篇

术前PTBD对肝门部胆管癌的疗效及安全性分析

吴海丰 袁阳春 林嘉瑜 谢阗 罗育青   

  1. 揭阳市人民医院
  • 通讯作者: 吴海丰

The effect and safety of preoperative PTBD for hilar cholangiocarcinoma

WU Haifeng,YUAN Yangchun,LIN Jiayu,XIE Tian,LUO Yuqing   

  • Online:2017-06-20 Published:2017-06-20

摘要:

 目的  探讨术前下经皮经肝胆管穿刺置管引流PTBD对拟行手术治疗的肝 部胆管癌患者的疗效及安全性。方法   2006 1 2016 12 月行手术治疗的肝门部胆 癌患 56 PTBD 32 对照组 24 例没有实 PTBD 患者比较两组患者围手术期有 指标的变化情结果  PTBD 组引流前后总胆红素分别 28134 umol/L1596 umol/L 后胆红素比引流前下差别有统计学意P<0.05而两组在术中出血胆汁细菌感染率 后并发症等差别无统计学差结论   PTBD 对于黄疸较严重的肝门部胆管癌患能有 的减轻黄疸是一种安全可行的办法能有效改善肝功能增强患者体质增加手术耐受力

关键词: PTBD, 疗效与安全性 , 手术, 肝门部胆管癌

Abstract:

 Objective To investigate the effect and safety of preoperative percutaneous transhe-patic biliary drainagePTBDfor the patients with hilar cholangiocarcinoma underwent operative treat-ment. Methods A total of 56 patients with hilar cholangiocarcinoma underwent operative treatment between January 2006 and December 2016, in whom 32 patients were subjected to PTBD before surgery PTBD groupand 24 patients without PTBD were assigned to controls. The changes of the perioperative indicators were compared between two groups of patients. Results The total bilirubin of PTBD group was 286 ± 134 umol/L before PTBD treatment, which was significantly reduced to 153 ± 96 μmol/L after treatment P<0.05. Moreover there was no significant difference of the incidence with blood loss intraoperative, the bacteria infection of bile and postoperative complications between the two groups. Conclusion PTBD is a safe and effective method to alleviate jaundice for the patients with hilar cholan-giocarcinoma before operation, which can improve the patients liver function, systemic general situation and the tolerance of the surgery.

Key words: hilar cholangiocarcinoma, PTBD, operation, effect and safety

中图分类号: